Data from regulatory studies: what do they tell? What don't they tell?
Author:
Publisher
Wiley
Subject
Neurology (clinical),Neurology,General Medicine
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1600-0404.2005.00504.x/fullpdf
Reference36 articles.
1. Drug trials in epilepsy
2. Multicenter Double-Blind, Randomized, Placebo-Controlled Trial of Levetiracetam as Add-On Therapy in Patients with Refractory Partial Seizures
3. Revisiting the Concept of Identifiable Neurons
4. A multicentre, double-blind, randomized, parallel group study to evaluate the tolerability and efficacy of two oral doses of levetiracetam, 2000 mg daily and 4000 mg daily, without titration in patients with refractory epilepsy
5. Dose–response effect of levetiracetam 1000 and 2000 mg/day in partial epilepsy
Cited by 11 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Predictors of seizure freedom, response and retention after 12 months of treatment with eslicarbazepine acetate: A post-hoc analysis of the Euro-Esli study;Epilepsy Research;2021-08
2. A retrospective analysis of using zonisamide and retention in monotherapy among patients with epilepsy in routine clinical practice;Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova;2019
3. Lacosamide efficacy and tolerability in clinical practice – Post marketing analysis from a single dedicated epilepsy center;Clinical Neurology and Neurosurgery;2018-08
4. Adjunctive lacosamide for focal epilepsy: an open-label trial evaluating the impact of flexible titration and dosing on safety and seizure outcomes;Epileptic Disorders;2017-06
5. Phase 4 (Postmarketing) Research;Essentials of Clinical Research;2014
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3